These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2427844)

  • 21. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
    Kohli RS; Lahiri A; Raftery EB
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S148-53. PubMed ID: 2439787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
    Klinger D
    Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S9-13. PubMed ID: 2481791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of bevantolol in the treatment of angina--a placebo-controlled study.
    Farnham DJ
    Angiology; 1986 Mar; 37(3 Pt 2):226-32. PubMed ID: 2871782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
    Jackson NC; Lee PS; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S145-7. PubMed ID: 2427846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
    Rodrigues EA; Lahiri A; Hughes LO; Kohli RS; Whittington JR; Raftery EB
    Am J Cardiol; 1986 Nov; 58(10):916-21. PubMed ID: 2877564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
    Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
    Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
    Bowles MJ; Khurmi NS; Bala Subramanian V; Raftery EB
    Int J Cardiol; 1984 Feb; 5(2):131-42. PubMed ID: 6365803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved left ventricular function during exercise: a comparison of celiprolol and atenolol.
    McLenachan J; Wilson J; Dargie H
    Am Heart J; 1988 Nov; 116(5 Pt 2):1435-6. PubMed ID: 2903655
    [No Abstract]   [Full Text] [Related]  

  • 38. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA; Crawford MH; O'Rourke RA
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.